Diagnostic value of global myocardial perfusion reserve assessment based on coronary sinus flow measurements using cardiovascular magnetic resonance in addition to myocardial stress perfusion imaging

European Heart Journal Cardiovascular Imaging

Volumn 18, Issue 8, 2017, Pages 851-859

  Shomanova, Zornitsa ^a   Florian, Anca ^a   Bietenbeck, Michael ^a   Waltenberger, Johannes ^a   Sechtem, Udo ^b   Yilmaz, Ali ^a  

^a UNIVERSITY HOSPITAL MÜNSTER   (Germany)

^b ROBERT BOSCH HOSPITAL   (Germany)

Author keywords

Cardiovascular magnetic resonance; Coronary artery disease; Coronary sinus flow; Myocardial blood flow; Myocardial perfusion reserve; SYNTAX

Indexed keywords

ADENOSINE; GADOBUTROL; GADOLINIUM;

ADULT; ARTICLE; CARDIOVASCULAR MAGNETIC RESONANCE; CARDIOVASCULAR PARAMETERS; CONTRAST ENHANCEMENT; CONTROLLED STUDY; CORONARY ANGIOGRAPHY; CORONARY SINUS; CORONARY SINUS FLOW VELOCITY ENCODED CINE; DIAGNOSTIC VALUE; FEMALE; FLOW MEASUREMENT; FLOW RATE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART MUSCLE BLOOD FLOW; HEART MUSCLE PERFUSION; HUMAN; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MYOCARDIAL PERFUSION IMAGING; MYOCARDIAL PERFUSION RESERVE; PREVALENCE; PRIORITY JOURNAL; SYNTAX SCORE; AGED; CINE MAGNETIC RESONANCE IMAGING; COHORT ANALYSIS; CORONARY ARTERY BLOOD FLOW; CORONARY ARTERY OBSTRUCTION; DIAGNOSTIC IMAGING; FRACTIONAL FLOW RESERVE; MAGNETIC RESONANCE ANGIOGRAPHY; PATHOPHYSIOLOGY; PHYSIOLOGY; PREDICTIVE VALUE; PROCEDURES; PROGNOSIS; RECEIVER OPERATING CHARACTERISTIC; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX;

AGED; COHORT STUDIES; CORONARY CIRCULATION; CORONARY STENOSIS; FEMALE; FRACTIONAL FLOW RESERVE, MYOCARDIAL; HUMANS; MAGNETIC RESONANCE ANGIOGRAPHY; MAGNETIC RESONANCE IMAGING, CINE; MALE; MIDDLE AGED; MYOCARDIAL PERFUSION IMAGING; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RISK ASSESSMENT; ROC CURVE; SEVERITY OF ILLNESS INDEX;

EID: 85025840307     PISSN: 20472404     EISSN: 20472412     Source Type: Journal    
DOI: 10.1093/ehjci/jew315     Document Type: Article

References (36)

1. Montalescot G, Sechtem U, Achenbach S, Andreotti F, Arden C, Budaj A et al. 2013 ESC guidelines on the management of stable coronary artery disease: the Task Force on the management of stable coronary artery disease of the European Society of Cardiology. Eur Heart J 2013;34:2949-3003.
2. Takx RA, Blomberg BA, El AH, Habets J, de Jong PA, Nagel E et al. Diagnostic ac-curacy of stress myocardial perfusion imaging compared to invasive coronary angiography with fractional flow reserve meta-analysis. Circ Cardiovasc Imaging 2015;8:pii:e002666.
3. Windecker S, Kolh P, Alfonso F, Collet JP, Cremer J, Falk V et al. 2014. ESC/EACTS Guidelines on myocardial revascularization. Kardiol Pol 2014;72:1253-379.
4. Camici PG, d'Amati G, Rimoldi O. Coronary microvascular dysfunction: mechanisms and functional assessment. Nat Rev Cardiol 2015;12:48-62.
5. Koskenvuo JW, Sakuma H, Niemi P, Toikka JO, Knuuti J, Laine H et al. Global myocardial blood flow and global flow reserve measurements by MRI and PET are comparable. J Magn Reson Imaging 2001;13:361-6.
6. Bloch KM, Carlsson M, Arheden H, Stahlberg F. Quantifying coronary sinus flow and global LV perfusion at 3T. BMC Med Imaging 2009;9:9.
7. Lund GK, Wendland MF, Shimakawa A, Arheden H, Stahlberg F, Higgins CB et al. Coronary sinus flow measurement by means of velocity-encoded cine MR imaging: validation by using flow probes in dogs. Radiology 2000;217:487-93.
8. Schwitter J, DeMarco T, Kneifel S, von Schulthess GK, Jorg MC, Arheden H et al. Magnetic resonance-based assessment of global coronary flow and flow reserve and its relation to left ventricular functional parameters: a comparison with positron emission tomography. Circulation 2000;101:2696-702.
9. van Rossum AC, Visser FC, Hofman MB, Galjee MA, Westerhof N, Valk J. Global left ventricular perfusion: noninvasive measurement with cine MR imaging and phase velocity mapping of coronary venous outflow. Radiology 1992;182:685-91.
10. Gyllenhammar T, Fernlund E, Jablonowski R, Jogi J, Engblom H, Liuba P et al. Young patients with hypertrophic cardiomyopathy, but not subjects at risk, show decreased myocardial perfusion reserve quantified with CMR. Eur Heart J Cardiovasc Imaging 2014;15:1350-7.
11. Kawada N, Sakuma H, Yamakado T, Takeda K, Isaka N, Nakano T et al. Hypertrophic cardiomyopathy: MR measurement of coronary blood flow and vasodilator flow reserve in patients and healthy subjects. Radiology 1999;211:129-35.
12. Watzinger N, Lund GK, Saeed M, Reddy GP, Araoz PA, Yang M et al. Myocardial blood flow in patients with dilated cardiomyopathy: quantitative assessment with velocity-encoded cine magnetic resonance imaging of the coronary sinus. J Magn Reson Imaging 2005;21:347-53.
13. Head SJ, Farooq V, Serruys PW, Kappetein AP. The SYNTAX score and its clinical implications. Heart 2014;100:169-77.
14. Mohr FW, Morice MC, Kappetein AP, Feldman TE, Stahle E, Colombo A et al. Coronary artery bypass graft surgery versus percutaneous coronary intervention in patients with three-vessel disease and left main coronary disease: 5-year follow-up of the randomised, clinical SYNTAX trial. Lancet 2013;381:629-38.
15. Serruys PW, Morice MC, Kappetein AP, Colombo A, Holmes DR, Mack MJ et al. Percutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery disease. N Engl J Med 2009;360:961-72.
16. Sianos G, Morel MA, Kappetein AP, Morice MC, Colombo A, Dawkins K et al. The SYNTAX Score: an angiographic tool grading the complexity of coronary artery disease. EuroIntervention 2005;1:219-27.
17. Garg S, Sarno G, Girasis C, Vranckx P, de VT, Swart M et al. A patient-level pooled analysis assessing the impact of the SYNTAX (synergy between percutaneous coronary intervention with taxus and cardiac surgery) score on 1-year clinical outcomes in 6, 508 patients enrolled in contemporary coronary stent trials. JACC Cardiovasc Interv 2011;4:645-53.
18. Wykrzykowska JJ, Garg S, Girasis C, de VT, Morel MA, van Es GA et al. Value of the SYNTAX score for risk assessment in the all-comers population of the randomized multicenter LEADERS (Limus Eluted from A Durable versus ERodable Stent coating) trial. J Am Coll Cardiol 2010;56:272-7.
19. Klem I, Heitner JF, Shah DJ, Sketch MH Jr, Behar V, Weinsaft J et al. Improved de-tection of coronary artery disease by stress perfusion cardiovascular magnetic resonance with the use of delayed enhancement infarction imaging. J Am Coll Cardiol 2006;47:1630-8.
20. Cerqueira MD, Weissman NJ, Dilsizian V, Jacobs AK, Kaul S, Laskey WK et al. Standardized myocardial segmentation and nomenclature for tomographic imag-ing of the heart. A statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association. Circulation 2002;105:539-42.
21. Dandekar VK, Bauml MA, Ertel AW, Dickens C, Gonzalez RC, Farzaneh-Far A. Assessment of global myocardial perfusion reserve using cardiovascular magnetic resonance of coronary sinus flow at 3 Tesla. J Cardiovasc Magn Reson 2014;16:24.
22. Kato S, Fukui K, Kawaguchi J, Ishii N, Koga M, Kusakawa Y et al. Relationship between coronary flow reserve evaluated by phase-contrast cine cardiovascular magnetic resonance and serum eicosapentaenoic acid. J Cardiovasc Magn Reson 2013;15:106.
23. Gould KL, Johnson NP, Bateman TM, Beanlands RS, Bengel FM, Bober R et al. Anatomic versus physiologic assessment of coronary artery disease. Role of coronary flow reserve, fractional flow reserve, and positron emission tomography imaging in revascularization decision-making. J Am Coll Cardiol 2013;62:1639-53.
24. Naya M, Murthy VL, Taqueti VR, Foster CR, Klein J, Garber M et al. Preserved coronary flow reserve effectively excludes high-risk coronary artery disease on angiography. J Nucl Med 2014;55:248-55.
25. Ziadi MC, deKemp RA, Williams K, Guo A, Renaud JM, Chow BJ et al. Does quantification of myocardial flow reserve using rubidium-82 positron emission tomography facilitate detection of multivessel coronary artery disease? J Nucl Cardiol 2012;19:670-80.
26. Shaw LJ, Berman DS, Picard MH, Friedrich MG, Kwong RY, Stone GW et al. Comparative definitions for moderate-severe ischemia in stress nuclear, echocar-diography, and magnetic resonance imaging. JACC Cardiovasc Imaging 2014;7:593-604.
27. Aras A, Anik Y, Demirci A, Balci NC, Kozdag G, Ural D et al. Magnetic resonance imaging measurement of left ventricular blood flow and coronary flow reserve in patients with chronic heart failure due to coronary artery disease. Acta Radiol 2007;48:1092-100.
28. Di CM, Czernin J, Hoh CK, Gerbaudo VH, Brunken RC, Huang SC et al. Relation among stenosis severity, myocardial blood flow, and flow reserve in patients with coronary artery disease. Circulation 1995;91:1944-51.
29. Schindler TH, Quercioli A, Valenta I, Ambrosio G, Wahl RL, Dilsizian V. Quantitative assessment of myocardial blood flow-clinical and research applications. Semin Nucl Med 2014;44:274-93.
30. Uren NG, Melin JA, de BB, Wijns W, Baudhuin T, Camici PG. Relation between myocardial blood flow and the severity of coronary-artery stenosis. N Engl J Med 1994;330:1782-8.
31. Uren NG, Camici PG, Melin JA, Bol A, de BB, Radvan J et al. Effect of aging on myocardial perfusion reserve. J Nucl Med 1995;36:2032-6.
32. Ben BF, Roubille F, Lattuca B, Cung TT, Macia JC, Gervasoni R et al. SPECT myo-cardial perfusion reserve in patients with multivessel coronary disease: correlation with angiographic findings and invasive fractional flow reserve measurements. J Nucl Med 2015;56:1712-7.
33. Danad I, Uusitalo V, Kero T, Saraste A, Raijmakers PG, Lammertsma AA et al. Quantitative assessment of myocardial perfusion in the detection of significant coronary artery disease: cutoff values and diagnostic accuracy of quantitative [(15)O]H2O PET imaging. J Am Coll Cardiol 2014;64:1464-75.
34. Reyes E, Underwood SR. Coronary anatomy and function: a story of Yin and Yang. Eur Heart J Cardiovasc Imaging 2015;16:831-3.
35. Yilmaz A, Athanasiadis A, Mahrholdt H, Voehringer M, Ong P, Hill S et al. Diagnostic value of perfusion cardiovascular magnetic resonance in patients with angina pectoris but normal coronary angiograms assessed by intracoronary acetylcholine testing. Heart 2010;96:372-9.
36. Yilmaz A, Sechtem U. Angina pectoris in patients with normal coronary angio-grams: current pathophysiological concepts and therapeutic options. Heart 2012;98:1020-9.